Avalon GloboCare Corp.
ALBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.27 | -2.46 | 3.56 |
| FCF Yield | -162.75% | -8.55% | -0.97% | -0.48% |
| EV / EBITDA | -1.56 | -5.64 | -92.57 | -123.87 |
| Quality | ||||
| ROIC | -32.98% | -98.44% | -54.33% | -138.42% |
| Gross Margin | 20.09% | 18.97% | 22.69% | 29.80% |
| Cash Conversion Ratio | 0.63 | 0.39 | 0.59 | 0.55 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.51% | -3.35% | -4.44% | -3.47% |
| Free Cash Flow Growth | 23.87% | 7.28% | -39.61% | 33.18% |
| Safety | ||||
| Net Debt / EBITDA | -0.96 | -0.56 | -0.33 | -0.29 |
| Interest Coverage | -2.02 | -11.66 | -2.46 | -44.06 |
| Efficiency | ||||
| Inventory Turnover | 11.55 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 65.25 | 68.21 | 40.87 | 23.85 |